This is the authors' abstract. We don't add key points for this paper.
Background: Cancer vaccine research has made significant progress in antigen discovery, delivery systems, and combination therapies. However, optimizing antigen selection and delivery remains a current challenge. To address this, we utilized oxidatively treated tumor cells as a source of antigens, effectively enhancing their immunogenicity. Inspired by the antigen delivery capabilities of dendritic cells (DCs) via extracellular vesicles, we developed a novel biomimetic nanovesicle vaccine, diA-MADCVac. This vaccine inherits the targeting ability of DCs, enabling precise antigen delivery to lymph nodes. Moreover, as a carrier, it efficiently delivers both adjuvants and intact tumor antigens, thereby playing a synergistic role in activating the immune system. Result: By targeting lymph nodes, diA-MADCVac effectively induces DCs maturation, activating tumor-specific T cell responses and generating trained immune memory. Furthermore, in a melanoma mouse model, diA-MADCVac significantly altered the tumor microenvironment, triggering a strong anti-tumor immune response and inhibiting tumor growth. This effect was characterized by increased secretion of cytokines such as IFN-γ and TNF-α in the tumor, along with a higher number of infiltrating T cells, which enhanced the immune system's tumor-killing capacity. Conclusion: use. This nanovesicle serves as an effective carrier, efficiently delivering both adjuvants and antigens to lymph nodes, thereby enhancing DC-mediated anti-tumor immune responses. Additionally, diA-MADCVac promotes trained immunity and enhances the tumor-killing capacity of immune cells. With its unique advantages, diA-MADCVac offers an efficient, safe, and promising new approach for tumor treatment, providing renewed hope for cancer patients.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Lu et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: